23 mar: Markedsoversigt: Aktier og renter tog endnu en tur nedad
30 mar: Valuta: Euro-skeptikerne slår bak
23-03-2012 18:54:00

UPDATE: EU Opens In-Depth Investigation Into Universal Buy Of EMI

Relateret indhold

--EU to investigate Universal takeover of EMI on competition grounds

--Universal says investigation was expected

--Decision expected by Aug. 8

(Updates with comment from Universal in the third paragraph)

By Frances Robinson and Matina Stevis


BRUSSELS -(Dow Jones)- The European Commission's antitrust arm will look in detail at the proposed acquisition by Vivendi SA's (VIVEF, VIV.FR) Universal Music Group of EMI's recorded music business, under the second phase of its merger review process, it said Friday.

"The commission's initial market investigation indicated that the proposed transaction may raise competition concerns in the wholesale of physical and digital recorded music in numerous member states as well as in the European Economic Area as a whole, particularly in light of the merged entity's high market shares and increased market power," the commission said.

Universal, in a statement issued soon after the investigation announcement, said that "Phase II was always expected; we recognise that the Commission needs time to fully review this transaction" and pledged to "continue to co-operate fully with them and look forward to a successful resolution of the process."

The commission's competition arm now has 90 working days, until Aug. 8, to look into the planned $1.9 billion transaction, which would create a new entity with control of roughly 40% of the global recorded music market, according to some estimates. EMI is home to stars including Blur, Iron Maiden, The Beatles and Katy Perry.

The commission's vice president in charge of competition policy, Joaquin Almunia, said: "The proposed acquisition could reduce competition in the recorded music market to the detriment of European consumers. The commission needs to make sure that consumers continue to have access to a wide variety of music in different physical and digital formats at competitive conditions."

It can decide to allow the deal to go ahead, ask for Vivendi to make concessions such as disposals, or block it completely, as it did recently with Deutsche Boerse (DBOEF, DB1.XE) and NYSE Euronext's (NYX) proposed merger.

The initial investigation has already led those opposed to voice their concerns and lobby the commission.

Edgar Bronfman Jr., on his final day as chairman of Warner Music Group in January, said the deal is "problematic" and that "Warner is going to fight this tooth and nail." IMPALA, which represents independent music labels, has said it wants an "outright no" to the proposed tie-up, which would push up music prices.

Citigroup Inc. (C) agreed to split up and sell the legendary U.K. music company in November, having previously seized the company from former owner Terra Firma Capital. In a separate deal, it will sell the music publishing business to a consortium led by rival Sony/ATV for $2.2 billion.

-By Frances Robinson and Matina Stevis, Dow Jones Newswires; +32499646573; frances.robinson@dowjones.com

(END) Dow Jones Newswires

March 23, 2012 14:54 ET (18:54 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg


Aktier/middag: Novozymes brager til bunds efter regnskabsskuffelse

26-10-2016 11:16:31
Novozymes løber med de fleste overskrifter på det danske aktiemarked onsdag, og desværre for enzymproducenten er nyhedsstrømmen af negativ karakter efter et sku..

Novo vil have flotte hjerte-kar-data på indlægssedlen for Victoza

26-10-2016 06:34:12
Medicinalselskabet Novo Nordisk vil have føjet endnu et salgsargument til indlægssedlen for den i forvejen storsælgende GLP-1-analog Victoza (Liraglutid).Derfor..

Smallcap DK Q3: Bundlinjen fordobles - fortsat usikkerhed på børserne

25-10-2016 15:57:29
Investeringsselskabet Smallcap Danmark leverede markant fremgang i tredje kvartal, men ser fortsat usikkerhed på aktiemarkederne generelt og venter et afkast fo..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
Novo/Sydbank: Rivals regnskab bekymrer
Tirsdagens aktier: Novos vending trak C20 fra plus til minus
Aktier/tendens: Novozymes står til kursstryg på regnskabstung morgen
Aktier/middag: Novozymes brager til bunds efter regnskabsskuffelse
Novo vil have flotte hjerte-kar-data på indlægssedlen for Victoza

Relaterede aktiekurser

Vivendi 18,12 -0,8% Fald i aktiekurs
Citigroup Inc 49,59 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2016  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
26. oktober 2016 13:22:02
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20161024.1 - EUROWEB6 - 2016-10-26 13:22:02 - 2016-10-26 13:22:02 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her